EDX Medical Group Plc (AQSE:EDX) is a global specialist in digital clinical diagnostics; developing and supporting high-performance products and services to provide cost-effective prediction of disease risk, inform clinical decision-making, enable personalised healthcare and accelerate the development of new medicines for cancer, neurology, heart disease and infectious diseases. EDX Medical entered into a strategic agreement with Guardant Health Inc., under which they distribute Guardant360® CDx and Guardant Reveal™.
![EDX Medical Group plc](https://directorstalk.net/wp-content/uploads/2024/05/EDX-Medical-Group-plc-300x300.png)
EDX Medical Group leading the charge in healthcare innovation
The healthcare sector is experiencing a remarkable transformation driven by advancements in technology and an increasing focus on personalised medicine. Among the significant trends shaping the industry are the integration of artificial intelligence (AI) and machine